Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic Review.


Journal

Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 25 11 2018
medline: 3 1 2020
entrez: 25 11 2018
Statut: ppublish

Résumé

Valid algorithms for identification of cardiovascular (CV) deaths allow researchers to reliably assess the CV safety of medications, which is of importance to regulatory science, patient safety, and public health. The aim was to conduct a systematic review of algorithms to identify CV death in administrative health plan claims databases. We searched MEDLINE, EMBASE, and Cochrane Library for English-language studies published between January 1, 2012 and October 17, 2017. We examined references in systematic reviews to identify earlier studies. Selection included any observational study using electronic health care data to evaluate the sensitivity, specificity, positive predictive value (PPV), or negative predictive value (NPV) of algorithms for CV death (sudden cardiac death [SCD], myocardial infarction [MI]-related death, or stroke-related death) among adults aged ≥ 18 years in the United States. Data were extracted by two independent reviewers, with disagreements resolved through further discussion and consensus. The Quality Assessment of Diagnostic Accuracy Studies-2 instrument was used to assess the risk of bias. Five studies (n = 4 on SCD, n = 1 on MI- and stroke-related death) were included after a review of 2053 citations. All studies reported algorithm PPVs, with incomplete reporting on other accuracy parameters. One study was at low risk of bias, three studies were at moderate risk of bias, and one study was at unclear risk of bias. Two studies identified community-occurring SCD: one identified events using International Classification of Disease, Ninth Revision (ICD-9) codes on death certificates and other criteria from medical claims (PPV = 86.8%) and the other identified events resulting in hospital presentation using first-listed ICD-9 codes on emergency department or inpatient medical claims (PPV = 92.3%). Two studies used death certificates alone to identify SCD (PPV = 27% and 32%, respectively). One study used medical claims to identify CV death (PPV = 36.4%), coronary heart disease mortality (PPV = 28.3%), and stroke mortality (PPV = 34.5%). Two existing algorithms based on medical claims diagnoses with or without death certificates can accurately identify SCD to support pharmacoepidemiologic studies. Developing valid algorithms identifying MI- and stroke-related death should be a research priority. PROSPERO 2017 CRD42017078745.

Identifiants

pubmed: 30471046
doi: 10.1007/s40264-018-0754-z
pii: 10.1007/s40264-018-0754-z
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-527

Subventions

Organisme : U.S. Food and Drug Administration
ID : HHSF22301012T
Pays : International

Références

N Engl J Med. 2012 May 17;366(20):1881-90
pubmed: 22591294
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Am J Cardiol. 2005 Apr 1;95(7):856-9
pubmed: 15781015
Circulation. 2012 Apr 17;125(15):1848-57
pubmed: 22420957
Aust N Z J Med. 1995 Aug;25(4):316-23
pubmed: 8540872
Am J Epidemiol. 1990 Nov;132(5):993-8
pubmed: 2239914
JAMA. 2012 Nov 7;308(17):1768-74
pubmed: 23117777
Diabetes Care. 2018 Apr;41(4):713-722
pubmed: 29437823
BMC Med Res Methodol. 2003 Nov 10;3:25
pubmed: 14606960
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):563-72
pubmed: 20029823
Ther Adv Cardiovasc Dis. 2018 Feb;12(2):39-51
pubmed: 29224509
PLoS One. 2014 Mar 28;9(3):e92286
pubmed: 24682186
Stroke. 1994 Dec;25(12):2348-55
pubmed: 7974572
Am J Cardiol. 1998 Jul 1;82(1):50-3
pubmed: 9671008
Ann Epidemiol. 1995 Jul;5(4):278-85
pubmed: 8520709
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:148-53
pubmed: 22262601
Int J Cardiol. 2015;187:705-11
pubmed: 25966015
Am J Epidemiol. 2007 Mar 1;165(5):591-6
pubmed: 17158473
J Epidemiol Community Health. 1998 Aug;52(8):513-9
pubmed: 9876363
PLoS One. 2015 Aug 20;10(8):e0135834
pubmed: 26292280
N Z Med J. 1988 Oct 26;101(856 Pt 1):658-60
pubmed: 3186004
J Clin Epidemiol. 1999 Feb;52(2):157-66
pubmed: 10201658
Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):555-62
pubmed: 19844945
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMC Res Notes. 2012 Aug 31;5:473
pubmed: 22938531
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:100-28
pubmed: 22262598
Circulation. 2015 Jul 28;132(4):302-61
pubmed: 25547519
Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:82-9
pubmed: 22262596

Auteurs

Sonal Singh (S)

Department of Family Medicine and Community Health and Meyers Primary Care Institute, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA, USA. Sonal.Singh@umassmemorial.org.

Hassan Fouayzi (H)

Department of Family Medicine and Community Health and Meyers Primary Care Institute, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA, USA.

Kathryn Anzuoni (K)

Department of Family Medicine and Community Health and Meyers Primary Care Institute, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA, USA.

Leah Goldman (L)

Department of Family Medicine and Community Health and Meyers Primary Care Institute, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA, USA.

Jea Young Min (JY)

Vanderbilt University Medical Center, Nashville, TN, USA.

Marie Griffin (M)

Vanderbilt University Medical Center, Nashville, TN, USA.

Carlos G Grijalva (CG)

Vanderbilt University Medical Center, Nashville, TN, USA.

James A Morrow (JA)

Vanderbilt University Medical Center, Nashville, TN, USA.

Christine C Whitmore (CC)

Vanderbilt University Medical Center, Nashville, TN, USA.

Charles E Leonard (CE)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Mano Selvan (M)

Humana/Comprehensive Health Insights, Inc., Louisville, KY, USA.

Vinit Nair (V)

Humana/Comprehensive Health Insights, Inc., Louisville, KY, USA.

Yunping Zhou (Y)

Humana/Comprehensive Health Insights, Inc., Louisville, KY, USA.

Sengwee Toh (S)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA, USA.

Andrew Petrone (A)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA, USA.

James Williams (J)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA, USA.

Elnara Fazio-Eynullayeva (E)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, MA, USA.

Richard Swain (R)

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.

D Tyler Coyle (D)

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD, USA.

Susan Andrade (S)

Department of Family Medicine and Community Health and Meyers Primary Care Institute, University of Massachusetts Medical School, 55 Lake Ave N, Worcester, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH